Close Menu

Little Soldiers

Infectious bacteria are becoming more than some clinicians can handle — they are increasingly resistant to antibiotics, and there are few new treatments being tested to combat them, says Not Exactly Rocket Science's Ed Yong. And as recent studies have shown, horizontal gene transfer is even more prevalent than previously thought, which means the bacteria can evolve more rapidly to resist drugs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.